CG
CRL icon

Cutler Group’s Charles River Laboratories CRL Stock Holding History

Cutler Group’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-394
Closed -$42K – 5029
2017
Q3 		$42K Buy
+394
New +$40.5K ﹤0.01% 2394
2016
Q3 		– Sell
-1,654
Closed -$139K – 6733
2016
Q2 		$136K Hold
1,654
– – 0.01% 1426
2016
Q1 		$125K Buy
1,654
+1,621
+4,912% +$120K 0.01% 1403
2015
Q4 		$2K Buy
+33
New +$2.38K ﹤0.01% 5516

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cutler Group's CRL Position: Q4 2017 in Review

Cutler Group sold out of Charles River Laboratories (CRL) in Q4 2017, closing a stake of 394 shares — an estimated $42K sold.

Cutler Group first reported a position in CRL in Q4 2015 and held it in 4 quarters. The position peaked at $136K in Q2 2016. 339 funds tracked by Wall St. Rank hold CRL as of Q4 2017.

  • Cutler Group reported no remaining Charles River Laboratories position as of Q4 2017 after selling out during the quarter.
  • Cutler Group sold 394 Charles River Laboratories shares in Q4 2017, an estimated $42K.
  • Cutler Group first reported a position in Charles River Laboratories in Q4 2015 and held it in 4 quarters.
  • Cutler Group's Charles River Laboratories position peaked at $136K in Q2 2016.
  • 339 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2017.

Based on Cutler Group's 13F filing for Q4 2017, filed 17 Jan 2018.